"
Team:Virginia/Documentary
From 2013.igem.org
| (6 intermediate revisions not shown) | |||
| Line 193: | Line 193: | ||
#menu11 ul li:hover span.text a{ | #menu11 ul li:hover span.text a{ | ||
text-decoration:none; | text-decoration:none; | ||
| - | color:# | + | color:#66CCFF; |
| + | } | ||
| + | #groupbio span { | ||
| + | font-size:20px; | ||
| + | text-decoration:underline; | ||
| + | padding-top:50px; | ||
} | } | ||
</style> | </style> | ||
| Line 222: | Line 227: | ||
<p><a href="https://2013.igem.org/Team:Virginia/Results">Results</a></p> | <p><a href="https://2013.igem.org/Team:Virginia/Results">Results</a></p> | ||
<p><a href="https://2013.igem.org/Team:Virginia/Modeling">Modeling</a></p> | <p><a href="https://2013.igem.org/Team:Virginia/Modeling">Modeling</a></p> | ||
| - | <p><a href="https://2013.igem.org/Team:Virginia/ | + | <p><a href="https://2013.igem.org/Team:Virginia/Software">Software</a></p> |
| + | |||
| + | <p><a href="https://2013.igem.org/Team:Virginia/Chassis_Improvements">Chassis Improvements</a></p></span> | ||
</li> | </li> | ||
<li> | <li> | ||
| Line 237: | Line 244: | ||
<p><a href="https://2013.igem.org/Team:Virginia/Human_Practices_Overview">Overview</a></p> | <p><a href="https://2013.igem.org/Team:Virginia/Human_Practices_Overview">Overview</a></p> | ||
<p><a href="https://2013.igem.org/Team:Virginia/Safety Considerations">Safety Considerations</a></p> | <p><a href="https://2013.igem.org/Team:Virginia/Safety Considerations">Safety Considerations</a></p> | ||
| - | <p><a href="https://2013.igem.org/Team:Virginia/ | + | <p><a href="https://2013.igem.org/Team:Virginia/High_School_Education_Series">High School Education Series</a></p> |
<p><a href="https://2013.igem.org/Team:Virginia/Documentary">Documentary</a></p> | <p><a href="https://2013.igem.org/Team:Virginia/Documentary">Documentary</a></p> | ||
| - | <p><a href="https://2013.igem.org/Team:Virginia/ | + | <p><a href="https://2013.igem.org/Team:Virginia/Media_Coverage">Media Coverage</a></p></span> |
| - | + | ||
</li> | </li> | ||
<li> | <li> | ||
| Line 260: | Line 266: | ||
<br><br> | <br><br> | ||
<p><center><span><iframe width="520" height="415" src="//www.youtube.com/embed/7KYlSghD2Sk" align="center" frameborder="0" allowfullscreen></iframe></span></center></p> | <p><center><span><iframe width="520" height="415" src="//www.youtube.com/embed/7KYlSghD2Sk" align="center" frameborder="0" allowfullscreen></iframe></span></center></p> | ||
| - | <div id="par"><p><center>(If the video has trouble loading, you can watch it directly on YouTube <a href="http://youtu.be/7KYlSghD2Sk">here</a>)</center></p></div> | + | <div id="par"><p><center>(If the video has trouble loading, you can watch it directly on YouTube <a href="http://youtu.be/7KYlSghD2Sk"><font color ="#66ccff">here</font></a>)</center></p></div> |
<br><br> | <br><br> | ||
</div> | </div> | ||
Latest revision as of 01:57, 29 October 2013
#
As synthetic biology continues to advance, the field’s bioethical implications continue to grow. To maintain safe practices and to not lose public support, scientists must keep these pressing concerns in mind.
We interviewed three experts in biology, medicine and bioethics and explored topics in biosafety, ownership in synthetic biology, and the potential impacts of our minicell research. We interviewed Dr. John Arras, a member of the U.S. Presidential Commission for the Study of Bioethical Issues, Dr. Alison Criss, an expert in microbiology, immunology and cancer biology in the UVa School of Medicine;,and Dr. Michael Timko, the Director of the Human Biology Program at UVa. As a result of conducting these interviews, we developed a better understanding of institutional and national biosafety regulations, intellectual property and ownership, and how these issues relate to the minicell chassis. Our goal for this film was not only to reach out to the iGEM audience, but to also make these issues accessible to the public.
